|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Liang G, Meng W, Huang X, Zhu W, Yin C,
Wang C, Fassan M, Yu Y, Kudo M, Xiao S, et al: miR-196b-5p-mediated
downregulation of TSPAN12 and GATA6 promotes tumor progression in
non-small cell lung cancer. Proc Natl Acad Sci USA. 117:4347–4357.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song JQ, Wang X, Zeng ZM, Liang PA, Zhong
CY and Liu AW: Efficacy of PD-1 inhibitors combined with
Anti-angiogenic therapy in driver gene mutation negative
Non-Small-cell lung cancer with brain metastases. Discov Med.
35:321–331. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zuo Y, Shen W, Wang C, Niu N and Pu J:
Circular RNA Circ-ZNF609 promotes lung adenocarcinoma proliferation
by modulating miR-1224-3p/ETV1 signaling. Cancer Manag Res.
12:2471–2479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rotte A: Combination of CTLA-4 and PD-1
blockers for treatment of cancer. J Exp Clin Cancer Res.
38:2552019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016.PubMed/NCBI
|
|
7
|
Li Y, Yang Y, Ma Q, Cheng H, Wang H, Ma C,
Li F, Zhao S, Li X, Qi Y and Gu Z: HNRNPK/CLCN3 axis facilitates
the progression of LUAD through CAF-tumor interaction. Int J Biol
Sci. 18:6084–6101. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu WJ, Wang L, Zhou FM, Liu SW, Wang W,
Zhao EJ, Yao QJ, Li W, Zhao YQ, Shi Z, et al: Elevated NOX4
promotes tumorigenesis and acquired EGFR-TKIs resistance via
enhancing IL-8/PD-L1 signaling in NSCLC. Drug Resist Updat.
70:1009872023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Y, Wang ZW, Su WH, Chen J and Wang YL:
Prognostic value and immune infiltrates of ABCA8 and FABP4 in
stomach adenocarcinoma. Biomed Res Int. 2020:41451642020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Cheng S, Fleishman JS, Chen J,
Tang H, Chen ZS, Chen W and Ding M: Targeting anoikis resistance as
a strategy for cancer therapy. Drug Resist Updat. 75:1010992024.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong B, Gu Y, Sun X, Wang X, Zhou Y, Rong
Z, Zhang J, Shi X, Zhang Z, He X, et al: Targeting TUBB3 suppresses
anoikis resistance and bone metastasis in prostate cancer. Adv
Healthc Mater. 13:e24006732024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
D'Amore T, Bravoco D, Di Paola G, Albano
F, Brancaccio M, Sabato C, Cesta G, Zolfanelli C, Lauciello V,
Falco G and Mazzone P: Anoikis resistance in gastric cancer: A
comprehensive review. Cell Death Dis. 16:5282025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Su Q and Li C: Identidication of
novel biomarkers in non-small cell lung cancer using machine
learning. Sci Rep. 12:166932022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Y, Liu X, Wang X, Zhang J, Li S and
Ma X: Comprehensive analysis of ABCA family members in lung
adenocarcinoma with prognostic values. Mol Biotechnol. 4:1441–1453.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu YJ, Huo YC, Zhao QT, Liu JY, Tian YJ,
Yang LL and Zhang Y: NOX4 promotes tumor progression through the
MAPK-MEK1/2-ERK1/2 axis in colorectal cancer. World J Gastrointest
Oncol. 16:1421–1436. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu T, Li Z, Gao CY and Cho CH: Mechanisms
of drug resistance in colon cancer and its therapeutic strategies.
World J Gastroenterol. 22:6876–6889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bharathiraja P, Yadav P, Sajid A, Ambudkar
SV and Prasad NR: Natural medicinal compounds target signal
transduction pathways to overcome ABC drug efflux
transporter-mediated multidrug resistance in cancer. Drug Resist
Updat. 71:1010042023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji N, Li H, Zhang Y, Li Y, Wang P, Chen X,
Liu YN, Wang JQ, Yang Y, Chen ZS, et al: Lansoprazole (LPZ)
reverses multidrug resistance (MDR) in cancer through impeding
ATP-binding cassette (ABC) transporter-mediated chemotherapeutic
drug efflux and lysosomal sequestration. Drug Resist Updat.
76:1011002024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha
Y, Li D, Alesi GN, Kang Y, Zhou L, et al: The PLAG1-GDH1 axis
promotes anoikis resistance and tumor metastasis through
CamKK2-AMPK signaling in LKB1-deficient lung cancer. Mol Cell.
69:87–99.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui Y, Liang S, Zhang S, Zhang C, Zhao Y,
Wu D, Wang J, Song R, Wang J, Yin D, et al: ABCA8 is regulated by
miR-374b-5p and inhibits proliferation and metastasis of
hepatocellular carcinoma through the ERK/ZEB1 pathway. J Exp Clin
Cancer Res. 39:902020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HJ, Kim D, Yoon H, Choi CS, Oh YS and
Jun HS: Prevention of oxidative Stress-induced pancreatic beta cell
damage by Broussonetia Kazinoki Siebold fruit extract via the
ERK-Nox4 pathway. Antioxidants (Basel). 9:4062020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim H, Sung JY, Park EK, Kho S, Koo KH,
Park SY, Goh SH, Jeon YK, Oh S, Park BK, et al: Regulation of
anoikis resistance by NADPH oxidase 4 and epidermal growth factor
receptor. Br J Cancer. 116:370–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Liu W, Zhang HM, Xie GY, Miao YR,
Xia M and Guo AY: hTFtarget: A comprehensive database for
regulations of human transcription factors and their targets.
Genomics Proteomics Bioinformatics. 18:120–128. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bao J, Li D, Wang L, Wu J, Hu Y, Wang Z,
Chen Y, Cao X, Jiang C, Yan W and Xu C: MicroRNA-449 and
microRNA-34b/c function redundantly in murine testes by targeting
E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway.
J Biol Chem. 287:21686–21698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Z, Wang T, Wu D, Min Z, Tan J and Yu
B: RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and
angiogenesis in colon cancer. J Exp Clin Cancer Res. 39:2032020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee CT, Li R, Zhu L, Tribble GD, Zheng WJ,
Ferguson B, Maddipati KR, Angelov N and Van Dyke TE: Subgingival
microbiome and Specialized Pro-Resolving lipid mediator pathway
profiles are correlated in periodontal inflammation. Front Immunol.
12:6912162021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song Z, Xiang X, Li J, Deng J, Fang Z,
Zhang L and Xiong J: Ruscogenin induces ferroptosis in pancreatic
cancer cells. Oncol Rep. 43:516–524. 2020.PubMed/NCBI
|
|
29
|
Guo X, Wang Z, Sun Q, Sun C, Hua H and
Huang Q: The inhibitory effect of microRNA-1827 on anoikis
resistance in lung adenocarcinoma A549 cells via targeting
caveolin-1. Acta Biochim Biophys Sin (Shanghai). 52:1148–1155.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiao Y, Li Y, Zhang J, Zhang S, Zha Y and
Wang J: RRM2 alleviates doxorubicin-induced Cardiotoxicity through
the AKT/mTOR signaling pathway. Biomolecules. 12:2992022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv C, Yang H, Yu J and Dai X: ABCA8
inhibits breast cancer cell proliferation by regulating the AMP
activated protein kinase/mammalian target of rapamycin signaling
pathway. Environ Toxicol. 37:1423–1431. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Basseres DS, D'Alò F, Yeap BY, Löwenberg
EC, Gonzalez DA, Yasuda H, Dayaram T, Kocher ON, Godleski JJ,
Richards WG, et al: Frequent downregulation of the transcription
factor Foxa2 in lung cancer through epigenetic silencing. Lung
Cancer. 77:31–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin S, He J, Zhou Y, Wu D, Li J and Gao W:
LncRNA FTX activates FOXA2 expression to inhibit non-small-cell
lung cancer proliferation and metastasis. J Cell Mol Med.
24:4839–4849. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim YN, Koo KH, Sung JY, Yun UJ and Kim H:
Anoikis resistance: An essential prerequisite for tumor metastasis.
Int J Cell Biol. 2012:3068792012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye G, Yang Q, Lei X, Zhu X, Li F, He J,
Chen H, Ling R, Zhang H, Lin T, et al: Nuclear MYH9-induced CTNNB1
transcription, targeted by staurosporin, promotes gastric cancer
cell anoikis resistance and metastasis. Theranostics. 10:7545–7560.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma M, Shi F, Zhai R, Wang H, Li K, Xu C,
Yao W and Zhou F: TGF-β promote epithelial-mesenchymal transition
via NF-κB/NOX4/ROS signal pathway in lung cancer cells. Mol Biol
Rep. 48:2365–2375. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhong X and Rescorla FJ: Cell surface
adhesion molecules and adhesion-initiated signaling: understanding
of anoikis resistance mechanisms and therapeutic opportunities.
Cell Signal. 24:393–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Lu H, Dazin P and Kapila Y:
Squamous cell carcinoma cell aggregates escape suspension-induced,
p53-mediated anoikis: Fibronectin and integrin alphav mediate
survival signals through focal adhesion kinase. J Biol Chem.
279:48342–48349. 2004. View Article : Google Scholar : PubMed/NCBI
|
